Showing results (111-120 of 418) with videos related to
Sort By:
Pageof 42
Journal of Neuroimmunology|December 20, 2005
CD25 regulatory T cells determine secondary but not primary remission in EAE: impact on long-term disease progressionDagmar Gärtner, Holger Hoff, Ulrike Gimsa, et al.Rheumatology (Oxford, England)|July 4, 2012
Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE studyVibeke Strand, Gerd R Burmester, Sarika Ogale, et al.Arthritis and Rheumatism|September 30, 2008
Reactivation of rheumatoid arthritis after pregnancy: increased phagocyte and recurring lymphocyte gene activityThomas Häupl, Monika Østensen, Andreas Grützkau, et al.Rheumatology (Oxford, England)|April 19, 2021
Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitorsRoy Fleischmann, Mark C Genovese, Karina Maslova, et al.BMJ Open|March 2, 2018
Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) patients (PREDICTRA)Paul Emery, Gerd R Burmester, Esperanza Naredo, et al.Annals of the Rheumatic Diseases|May 15, 2017
High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart blockAnna R Lisney, Franziska Szelinski, Karin Reiter, et al.Annals of the Rheumatic Diseases|May 27, 2011
Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human studyGerd R Burmester, Eugen Feist, Matthew A Sleeman, et al.Clinical Rheumatology|May 20, 2023
Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trialEric L Matteson, Martin Aringer, Gerd R Burmester, et al.BMC Cell Biology|June 25, 2010
Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiationZahia Hamidouche, Olivia Fromigué, Jochen Ringe, et al.Trends in Biotechnology|July 13, 2004
Scaffold-based tissue engineering: rationale for computer-aided design and solid free-form fabrication systemsDietmar W Hutmacher, Michael Sittinger, Makarand V RisbudPageof 42